Recent questions tagged prescription-drugs

0 votes

0 answers 69 views

Medicare Drug Price Negotiation Program -- CMS invites comment on initial guidance (by 4/14)

asked 10 days ago by Andrew Reamer (41k points)

0 votes

0 answers 51 views

Medicare Prescription Drug Inflation Rebate Program -- CMS seeks input on initial guidance (by 3/11)

asked 1 month ago by Andrew Reamer (41k points)

0 votes

0 answers 235 views

Dosage/Administration Labeling for Prescription Drugs -- FDA invites comments on draft guidance (by 3/14)

asked 2 months ago by Andrew Reamer (41k points)

0 votes

0 answers 142 views

Medicare Advantage (MA) Plans & Prescription Drug Plans (PDP) Bid Pricing Tool -- CMS invites comments to OMB (by 2/13)

asked 2 months ago by Andrew Reamer (41k points)

0 votes

0 answers 73 views

Medicare Drug Price Negotiation Program -- CMS Announces Key Y1 Dates (1.11.23)

asked 2 months ago by Andrew Reamer (41k points)

0 votes

0 answers 273 views

CMS 2024 Proposed Changes to Medicare Advantage/Medicare Part D Programs--comments invited (by 2/13)

asked 3 months ago by Andrew Reamer (41k points)

0 votes

0 answers 261 views

Prescription Drug Prices 2016-2022 and Spending 2016-2021 -- ASPE reports (9.30.22)

asked 5 months ago by Andrew Reamer (41k points)

0 votes

0 answers 192 views

Intl Prescription Drug Price Comparisons: Current Empirical Estimates/Comparisons w/ Previous Studies -- ASPE (7.1.22)

asked 8 months ago by Andrew Reamer (41k points)

0 votes

0 answers 902 views

Prescription Drug/Health Care Spending Data Collection (RxDC) -- CMS invites comments to OMB (by 7/28)

asked 8 months ago by Andrew Reamer (41k points)

0 votes

0 answers 193 views

Prescription Drug Promotion Research -- FDA invites comments on proposed tradeoff analysis (by 6/24)

asked 11 months ago by Andrew Reamer (41k points)

0 votes

0 answers 539 views

Impact of PBM Business Practices on Drug Affordability/Access -- FTC requests information (by 5/25)

asked 1 year ago by Andrew Reamer (41k points)

0 votes

0 answers 281 views

Medicare Advantage and Part D Proposed Rule for 2023 -- CMS invites comments (by 3/7)

asked 1 year ago by Andrew Reamer (41k points)

0 votes

0 answers 202 views

Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships -- ASPE issues RAND report (10/14)

asked 1 year ago by Andrew Reamer (41k points)

0 votes

0 answers 384 views

Annual Drug/Health Care Spending Data Collection -- CMS/EBSA/IRS/OPM invite comments on interim rule (by 1/24)

asked 1 year ago by Andrew Reamer (41k points)

0 votes

0 answers 452 views

Enhancing Safety/Security of Pharma Distribution Supply Chain -- FDA public mtg (11/16), seeks comments (by 1/18)

asked 1 year ago by Andrew Reamer (41k points)

0 votes

0 answers 169 views

Prescription Drug Event (PDE) Data Collection from Part D Providers -- CMS invites comment to OMB (by 10/4)

asked 1 year ago by Andrew Reamer (41k points)

0 votes

0 answers 370 views

Prescription Drug Data for Medicare Part D Payments -- CMS invites comments on proposed collection (by 8/23)

asked 1 year ago by Andrew Reamer (41k points)

To see more, click for the full list of questions or popular tags.

...